Xu WW - Search Results

1

The Establishment of an HE4-CLIA Method and the Combined Analysis of HE4 and CA125 in Ovarian Cancer.

Zhang Q, Wang CR, Yu JP, Ma Q, Xu WW. Zhang Q, et al. Among authors: xu ww. J Clin Lab Anal. 2016 Sep;30(5):709-18. doi: 10.1002/jcla.21926. Epub 2016 Mar 17. J Clin Lab Anal. 2016. PMID: 26990679 Free PMC article.

2

Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.

Yu JP, Xu XG, Ma RJ, Qin SN, Wang CR, Wang XB, Li M, Li MS, Ma Q, Xu WW. Yu JP, et al. Among authors: xu xg, xu ww. J Clin Lab Anal. 2015 Mar;29(2):85-93. doi: 10.1002/jcla.21733. Epub 2014 Mar 28. J Clin Lab Anal. 2015. PMID: 24687454 Free PMC article.

3

Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis.

Yu J, Ma Q, Zhang B, Ma R, Xu X, Li M, Xu W, Li M. Yu J, et al. Sci China Life Sci. 2013 Mar;56(3):234-9. doi: 10.1007/s11427-013-4451-y. Epub 2013 Mar 23. Sci China Life Sci. 2013. PMID: 23526389 Free article.

4

Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3.

Xie C, Tiede C, Zhang X, Wang C, Li Z, Xu X, McPherson MJ, Tomlinson DC, Xu W. Xie C, et al. Sci Rep. 2017 Aug 29;7(1):9608. doi: 10.1038/s41598-017-10083-w. Sci Rep. 2017. PMID: 28852111 Free PMC article.

5

Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.

Wang C, Shao X, Zhang X, Xie C, Yu J, Xu X, Yang J, Li Y, Xu W. Wang C, et al. Transl Cancer Res. 2020 Jan;9(1):128-136. doi: 10.21037/tcr.2019.11.20. Transl Cancer Res. 2020. PMID: 35117166 Free PMC article.

6

Rapid and Sensitive Lateral Flow Immunoassay Method for Procalcitonin (PCT) Based on Time-Resolved Immunochromatography.

Shao XY, Wang CR, Xie CM, Wang XG, Liang RL, Xu WW. Shao XY, et al. Among authors: xu ww. Sensors (Basel). 2017 Feb 28;17(3):480. doi: 10.3390/s17030480. Sensors (Basel). 2017. PMID: 28264502 Free PMC article.

7

Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.

Chen JJ, Xie CM, Wang CR, Wan Y, Dong ZN, Li M, Xu WW. Chen JJ, et al. Among authors: xu ww. J Fluoresc. 2017 Jul;27(4):1479-1485. doi: 10.1007/s10895-017-2087-1. Epub 2017 Apr 20. J Fluoresc. 2017. PMID: 28429175

8

Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.

Huang M, Geng Y, Deng Q, Li R, Shao X, Zhang Z, Xu W, Wu Y, Ma Q. Huang M, et al. Int J Oncol. 2018 Oct;53(4):1481-1492. doi: 10.3892/ijo.2018.4502. Epub 2018 Jul 25. Int J Oncol. 2018. PMID: 30066846 Free PMC article.

9

[Preparation of time-resolved fluoroimmunoassay kit for human alpha-fetoprotein detection].

Hang JF, Wu YS, Yu WH, Xu WW, Wang CR, Qiu YR, Li M. Hang JF, et al. Among authors: xu ww. Di Yi Jun Yi Da Xue Xue Bao. 2005 Mar;25(3):313-7. Di Yi Jun Yi Da Xue Xue Bao. 2005. PMID: 15772001 Chinese.

10

The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells.

Ma Q, Geng Y, Xu W, Wu Y, He F, Shu W, Huang M, Du H, Li M. Ma Q, et al. J Proteome Res. 2010 Jan;9(1):40-9. doi: 10.1021/pr9001367. J Proteome Res. 2010. PMID: 19621893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters